S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Will the Energy Sector Continue to Outshine the Market?
This Stock Could Go Up 66% or More. (Ad)
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
MarketBeat Week in Review – 9/25 - 9/29
This Stock Could Go Up 66% or More. (Ad)
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
This Stock Could Go Up 66% or More. (Ad)
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Federal agency sues Chipotle after a Kansas manager allegedly ripped off an employee's hijab
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Will the Energy Sector Continue to Outshine the Market?
This Stock Could Go Up 66% or More. (Ad)
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
MarketBeat Week in Review – 9/25 - 9/29
This Stock Could Go Up 66% or More. (Ad)
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
This Stock Could Go Up 66% or More. (Ad)
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Federal agency sues Chipotle after a Kansas manager allegedly ripped off an employee's hijab
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Will the Energy Sector Continue to Outshine the Market?
This Stock Could Go Up 66% or More. (Ad)
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
MarketBeat Week in Review – 9/25 - 9/29
This Stock Could Go Up 66% or More. (Ad)
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
This Stock Could Go Up 66% or More. (Ad)
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Federal agency sues Chipotle after a Kansas manager allegedly ripped off an employee's hijab
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Will the Energy Sector Continue to Outshine the Market?
This Stock Could Go Up 66% or More. (Ad)
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
MarketBeat Week in Review – 9/25 - 9/29
This Stock Could Go Up 66% or More. (Ad)
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
This Stock Could Go Up 66% or More. (Ad)
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Federal agency sues Chipotle after a Kansas manager allegedly ripped off an employee's hijab
NASDAQ:ATRC

AtriCure (ATRC) Stock Forecast, Price & News

$43.80
-0.11 (-0.25%)
(As of 09/29/2023 ET)
Compare
Today's Range
$43.54
$44.64
50-Day Range
$41.12
$57.73
52-Week Range
$32.51
$59.61
Volume
403,778 shs
Average Volume
301,862 shs
Market Capitalization
$2.08 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$65.00

AtriCure MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
48.4% Upside
$65.00 Price Target
Short Interest
Bearish
2.83% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.89mentions of AtriCure in the last 14 days
Based on 7 Articles This Week
Insider Trading
Selling Shares
$195,077 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($0.93) to ($0.74) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.23 out of 5 stars

Medical Sector

391st out of 972 stocks

Surgical & Medical Instruments Industry

48th out of 96 stocks


ATRC stock logo

About AtriCure (NASDAQ:ATRC) Stock

AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation and ablate cardiac tissue with the same device; and the Coolrail device, which enable users to make longer linear lines of ablation. It also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Guided Coagulation System, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure compatible with a range of anatomical shapes. In addition, the company sells Lumitip Dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; Subtle Cannula's to support access for EPi-Sense catheters; and various reusable cardiac surgery instruments, which are used during surgical procedures for repair or replacement of certain heart valves. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.

ATRC Price History

ATRC Stock News Headlines

AtriCure (NASDAQ:ATRC) Coverage Initiated at UBS Group
U.S. Loses to China in Shocking WAR GAMES
=== BREAKING === U.S. Loses to China in Shocking WAR GAMES Pentagon says new "living missile" key to winning a future conflict. Investors stand to reap 35,960% on shares of the small defense contractor that makes powerful new weapon. Get the name of the stock here >>>
U.S. Loses to China in Shocking WAR GAMES
=== BREAKING === U.S. Loses to China in Shocking WAR GAMES Pentagon says new "living missile" key to winning a future conflict. Investors stand to reap 35,960% on shares of the small defense contractor that makes powerful new weapon. Get the name of the stock here >>>
AtriCure: Q2 Earnings Snapshot
Q2 2023 AtriCure Inc Earnings Call
What Wall Street expects from AtriCure's earnings
AtriCure: Operating Leverage Is Required As A Cure
ATRC - AtriCure, Inc.
Needham Reaffirms Their Buy Rating on Atricure (ATRC)
AtriCure, Inc. (ATRC)
Q1 2023 AtriCure Inc Earnings Call
See More Headlines
Receive ATRC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AtriCure and its competitors with MarketBeat's FREE daily newsletter.

ATRC Company Calendar

Last Earnings
7/25/2023
Today
10/01/2023
Next Earnings (Estimated)
11/07/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
Sector
Medical
Current Symbol
NASDAQ:ATRC
CUSIP
04963C20
Employees
1,050
Year Founded
2000

Price Target and Rating

Average Stock Price Forecast
$65.00
High Stock Price Forecast
$74.00
Low Stock Price Forecast
$56.00
Forecasted Upside/Downside
+48.4%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
5 Analysts

Profitability

Net Income
$-46,470,000.00
Pretax Margin
-7.57%

Debt

Sales & Book Value

Annual Sales
$330.38 million
Book Value
$9.82 per share

Miscellaneous

Free Float
45,978,000
Market Cap
$2.08 billion
Optionable
Optionable
Beta
1.37

Social Links

The Best High-Yield Dividend Stocks for 2023 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

  • Mr. Michael H. Carrel (Age 52)
    CEO, Pres & Director
    Comp: $1.62M
  • Ms. Angela L. Wirick CPAMs. Angela L. Wirick CPA (Age 45)
    Chief Financial Officer
    Comp: $668.62k
  • Mr. Douglas J. SeithMr. Douglas J. Seith (Age 57)
    Chief Operating Officer
    Comp: $989.17k
  • Mr. Justin J. NozneskyMr. Justin J. Noznesky (Age 45)
    Chief Marketing & Strategy Officer
    Comp: $644.73k
  • Ms. Deborah Yount (Age 57)
    Chief HR Officer
    Comp: $498.36k
  • Mr. Salvatore Privitera J.D.Mr. Salvatore Privitera J.D. (Age 56)
    Chief Technical Officer
  • Dr. Vinayak Doraiswamy Ph.D. (Age 51)
    Chief Scientific Officer
  • Mr. Karl S. Dahlquist C.C.E.P. (Age 53)
    CCEP, J.D., Chief Legal Officer
  • Valerie Storch-Willhaus
    VP of Corp. Marketing & Communications













ATRC Stock - Frequently Asked Questions

Should I buy or sell AtriCure stock right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for AtriCure in the last year. There are currently 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" ATRC shares.
View ATRC analyst ratings
or view top-rated stocks.

What is AtriCure's stock price forecast for 2023?

5 Wall Street research analysts have issued twelve-month target prices for AtriCure's stock. Their ATRC share price forecasts range from $56.00 to $74.00. On average, they predict the company's stock price to reach $65.00 in the next year. This suggests a possible upside of 48.4% from the stock's current price.
View analysts price targets for ATRC
or view top-rated stocks among Wall Street analysts.

How have ATRC shares performed in 2023?

AtriCure's stock was trading at $44.38 on January 1st, 2023. Since then, ATRC stock has decreased by 1.3% and is now trading at $43.80.
View the best growth stocks for 2023 here
.

When is AtriCure's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 7th 2023.
View our ATRC earnings forecast
.

How were AtriCure's earnings last quarter?

AtriCure, Inc. (NASDAQ:ATRC) released its earnings results on Tuesday, July, 25th. The medical device company reported ($0.12) EPS for the quarter, beating the consensus estimate of ($0.27) by $0.15. The medical device company had revenue of $100.92 million for the quarter, compared to analyst estimates of $97.55 million. AtriCure had a negative trailing twelve-month return on equity of 7.11% and a negative net margin of 7.67%. The company's revenue for the quarter was up 19.4% compared to the same quarter last year. During the same period in the prior year, the company posted ($0.32) EPS.

What guidance has AtriCure issued on next quarter's earnings?

AtriCure issued an update on its FY 2023 earnings guidance on Tuesday, July, 25th. The company provided EPS guidance of -$0.94--$0.92 for the period, compared to the consensus EPS estimate of -$1.02. The company issued revenue guidance of $392.00 million-$395.00 million, compared to the consensus revenue estimate of $388.31 million.

What is Michael Carrel's approval rating as AtriCure's CEO?

38 employees have rated AtriCure Chief Executive Officer Michael Carrel on Glassdoor.com. Michael Carrel has an approval rating of 100% among the company's employees. This puts Michael Carrel in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. 93.0% of employees surveyed would recommend working at AtriCure to a friend.

What other stocks do shareholders of AtriCure own?
What is AtriCure's stock symbol?

AtriCure trades on the NASDAQ under the ticker symbol "ATRC."

How do I buy shares of AtriCure?

Shares of ATRC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is AtriCure's stock price today?

One share of ATRC stock can currently be purchased for approximately $43.80.

How much money does AtriCure make?

AtriCure (NASDAQ:ATRC) has a market capitalization of $2.08 billion and generates $330.38 million in revenue each year. The medical device company earns $-46,470,000.00 in net income (profit) each year or ($0.61) on an earnings per share basis.

How many employees does AtriCure have?

The company employs 1,050 workers across the globe.

Does AtriCure have any subsidiaries?
The following companies are subsidiares of AtriCure: SentreHEART.
Read More
How can I contact AtriCure?

AtriCure's mailing address is 7555 INNOVATION WAY, MASON OH, 45040. The official website for the company is www.atricure.com. The medical device company can be reached via phone at (513) 755-4100, via email at lynn@gilmartinir.com, or via fax at 513-755-4567.

This page (NASDAQ:ATRC) was last updated on 10/1/2023 by MarketBeat.com Staff

My Account -